一个单臂的abemaciclib的2期研究,在患有复发性3级寡头质瘤的成年患者中进行

Carson A Wills1, Suyash Mohan2, Ali Nabavizadeh2

  • 1Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Neuro-oncology advances
|February 13, 2025
PubMed
概括

阿贝马西克利布在治疗复发性寡质瘤的单一治疗中表现出有限的疗效. 虽然一些患者经历了部分反应,但总体无进展生存期没有达到试验的标准.